Bausch + Lomb Corp: Agreement Termination & Officer Changes
Ticker: BLCO · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1860742
Sentiment: neutral
Topics: agreement-termination, management-change, compensation
Related Tickers: BLCO
TL;DR
BLCO terminated a deal, swapped some execs, and changed comp plans. Watch for impacts.
AI Summary
Bausch + Lomb Corporation announced on August 14, 2025, the termination of a material definitive agreement. The company also reported changes in its board of directors and certain officers, including the election of new directors and the appointment of new officers. Additionally, compensatory arrangements for certain officers were disclosed.
Why It Matters
This filing indicates significant corporate actions, including the end of a key agreement and potential shifts in leadership and compensation structures, which could impact the company's strategic direction and financial performance.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and changes in officers/directors can signal underlying business issues or strategic shifts that may carry financial or operational risks.
Key Players & Entities
- Bausch + Lomb Corporation (company) — Registrant
- August 14, 2025 (date) — Date of Report
FAQ
What was the material definitive agreement that was terminated?
The filing does not specify the details of the material definitive agreement that was terminated.
When was the termination of the material definitive agreement effective?
The filing states the date of the earliest event reported is August 14, 2025, implying the termination occurred on or before this date.
Were there any specific reasons cited for the termination of the agreement?
The filing does not provide specific reasons for the termination of the material definitive agreement.
Who are the newly elected directors or appointed officers?
The filing indicates the election of directors and appointment of officers but does not name the individuals involved.
What are the details of the compensatory arrangements for certain officers?
The filing mentions compensatory arrangements but does not provide specific details within the provided text.
Filing Stats: 768 words · 3 min read · ~3 pages · Grade level 9.9 · Accepted 2025-08-18 17:06:46
Filing Documents
- blco-20250814.htm (8-K) — 30KB
- blpressrelease.htm (EX-99.1) — 8KB
- bllogo-hiresa.jpg (GRAPHIC) — 218KB
- 0001860742-25-000019.txt ( ) — 450KB
- blco-20250814.xsd (EX-101.SCH) — 2KB
- blco-20250814_lab.xml (EX-101.LAB) — 22KB
- blco-20250814_pre.xml (EX-101.PRE) — 13KB
- blco-20250814_htm.xml (XML) — 3KB
02 Termination of a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement. In accordance with its terms, the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022 (the "Director Appointment and Nomination Agreement"), by and among Carl C. Icahn, Icahn Partners LP, Icahn Partners Master Fund LP, Icahn Enterprises G.P. Inc., Icahn Enterprises Holdings L.P., IPH GP LLC, Icahn Capital LP, Icahn Onshore LP, Icahn Offshore LP and Beckton Corp. (collectively, the "Icahn Group") and Bausch + Lomb Corporation ("Bausch + Lomb") has terminated following the Icahn Group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., falling below the required threshold in the Director Appointment and Nomination Agreement. The termination of the Director Appointment and Nomination Agreement was effective as of August 14, 2025. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective August 14, 2025, Brett Icahn and Gary Hu resigned from the board of directors (the "Board") of Bausch + Lomb in connection with the termination of the Director Appointment and Nomination Agreement. Messrs. Icahn and Hu were appointees of the Icahn Group and had been members of the Board since June 2022. Mr. Hu served as a member of the Audit and Risk Committee, the Talent and Compensation Committee and the Science and Technology Committee of the Board until the time of his resignation. The resignations of Messrs. Icahn and Hu did not result from any disagreement with Bausch + Lomb.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 18, 2025, Bausch + Lomb issued a press release announcing the foregoing updates. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Press Release, dated August 18, 2025 104* Cover Page Interactive Data File (formatted as Inline XBRL) ____________________________________ * Filed herewith.
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BAUSCH + LOMB CORPORATION By: /s/ A. Robert D. Bailey Name: A. Robert D. Bailey Title: Executive Vice President and Chief Legal Officer Date: August 18, 2025